Image-Guided Therapy Systems Market to Hit USD 11.16 Billion by 2033 | AI-Driven Imaging, Minimally Invasive Surgery & Precision Oncology Fuel 6.1% CAGR

The Global Image-guided Therapy Systems Market size reached USD 5.75 billion in 2024 and is projected to reach USD 11.16 billion by 2033, growing at a CAGR of 6.1% from 2025 to 2033. This robust growth is driven by the rising demand for minimally invasive procedures, advancements in imaging technologies including AI integration and 3D visualization, increasing prevalence of chronic diseases such as cancer and cardiovascular conditions, growing geriatric population, and supportive government initiatives for precision medicine and favorable reimbursement policies.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/image-guided-therapy-systems-market?sindhuri

North America: Key Industry Developments (Largest Region)
✅ November 2025: GE Healthcare expanded its image-guided systems portfolio with AI-enabled enhancements for real-time navigation in oncology and cardiology procedures across major U.S. hospitals.
✅ July 2025: Philips received FDA 510(k) clearance for an updated UroNav system, featuring advanced fusion of MRI and ultrasound for precise prostate cancer focal therapy.
✅ February 2025: Royal Philips launched the Azurion neuro biplane system, enhancing neurovascular procedures with improved 2D/3D imaging and flexible detector positioning for faster decision-making.

Asia Pacific: Key Industry Developments (Fastest Growing Region)
✅ November 2025: Siemens Healthineers introduced tailored image-guided solutions for high-volume cardiac and oncology interventions in key markets like China and India.
✅ October 2025: Government initiatives in India and China boosted investments in minimally invasive infrastructure, subsidizing adoption in expanding hospitals.
✅ September 2025: Canon Medical Systems partnered with regional providers to deploy advanced CT and ultrasound-guided systems, addressing rising chronic disease burdens in urban centers.
Key Mergers and Acquisitions (2025):
✅ Siemens Healthineers strengthens oncology portfolio: Ongoing integration and strategic acquisitions in radiation therapy and imaging to enhance image-guided precision.
✅ Philips advances neuro and urology platforms: Partnerships and enhancements targeting AI-integrated systems for minimally invasive therapies.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=image-guided-therapy-systems-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)

Market Segmentation Analysis:
-By Product Type: Computed Tomography (CT) Scanners Lead with Dominant Share
The Computed Tomography (CT) Scanners segment commands the largest market share due to high demand for real-time, high-resolution imaging in neurology, cardiology, and oncology, supported by AI integration and intraoperative capabilities.

Other segments include Ultrasound Systems, MRI, Endoscopes, X-ray Fluoroscopy, PET, and SPECT. Ambulatory Surgical Centers are emerging as a fast-growing end-user segment due to cost savings and preference for same-day procedures.

-By Application: Oncology and Cardiology Top with Strong Demand
Oncology Surgery and Cardiac Surgery remain foundational applications, driven by precision needs in tumor ablation and interventional cardiology.
Neurosurgery and Orthopedic Surgery are high-growth areas, fueled by advancements in real-time navigation and minimally invasive techniques.

-By End User: Hospitals Command Largest Portion
Hospitals hold the leading share due to high procedure volumes and advanced infrastructure.
Ambulatory Surgical Centers are the fastest-growing, supported by shorter recovery times and cost efficiencies.

Growth Drivers:
Rising Demand for Minimally Invasive Procedures: Patient preferences for reduced complications, pain, and recovery times drive adoption of image-guided systems.
Technological Advancements in Imaging and AI: Integration of AI, 3D visualization, and real-time navigation enhances accuracy and outcomes.
Increasing Prevalence of Chronic Diseases: Growing burden of cancer, cardiovascular, and neurological disorders necessitates precise interventions.
Geriatric Population Growth: Aging demographics increase need for low-trauma, targeted therapies.
Supportive Reimbursement and Government Policies: Favorable policies and funding for precision medicine accelerate market expansion.

Speak to Our Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/image-guided-therapy-systems-market?sindhuri

Regional Insights:
North America dominates the global Image-guided Therapy Systems market, accounting for the largest share (estimated at over 40% in 2024). This leadership is due to advanced healthcare infrastructure, high adoption of innovative technologies, presence of major players like GE Healthcare and Philips, rising chronic disease prevalence, and supportive reimbursement frameworks.
Asia-Pacific is the fastest-growing region, driven by expanding healthcare investments, rapid infrastructure development, increasing geriatric population, and rising demand for minimally invasive treatments in countries like China and India.

Key Players:
Philips Healthcare | Siemens Healthineers | GE Healthcare | Medtronic | Brainlab AG | Olympus Corporation | Stryker Corporation | Varian Medical Systems (Siemens Healthineers) | Elekta AB | Canon Medical Systems

Key Highlights (Top 5 Key Players) for Image-guided Therapy Systems Market:
1. Philips Healthcare maintains leadership with its Azurion platform, offering integrated image-guided solutions for neuro, cardiac, and oncology procedures with advanced AI workflows.
2. Siemens Healthineers excels in multi-modality imaging and oncology, leveraging Varian integration for precise radiation and interventional therapies.
3. GE Healthcare dominates with high-resolution systems and AI enhancements, supporting complex interventions in cardiology and oncology.
4. Medtronic provides robust navigation and robotic-assisted platforms, focusing on neurosurgery and spine applications for superior precision.
5. Stryker innovates in orthopedic and neuro image-guided tools, emphasizing real-time visualization and minimally invasive surgical efficiency.

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.